Search
for
Sort by
Research 151–180 of 1000+
- Cardiac flow parameters with conventional and pulsed tissue Doppler echocardiography imaging in patients with polycystic ovary syndrome
- Acarbose for Polycystic Ovary Syndrome
- Clinical Patterns of Hair Loss in Men
- Orthostatic symptoms in women treated with low-dose oral minoxidil in the absence of overt hypotension: Implications for clinical practice
- The role of high serum uric acid levels in androgenic and non-androgenic polycystic ovarian syndrome patients
- Clinical Characteristics of Female Patterned Hair Loss in Patients Attending Hair Clinic in Thailand
- Evaluation of Serum Ischemia Modified Albumin Level in Male Patients with Androgenetic Alopecia
- The effectiveness of exercise in the treatment of polycystic ovary syndrome
- Association between Lipid Accumulation Product and Hirsutism in Patients with Polycystic Ovary Syndrome
- Evaluation of Anthropometric Measurements, Arterial Stiffness and ECG Parameters in Alopecia Areata Patients
- 63835 Exploring the Link Between Metabolic Syndrome and Female Pattern Hair Loss: A Systematic Review
- A hospital-based study to assess the prevalence of Androgenetic alopecia in young male patients admitted to a Cardiac care unit (2021)
- Combination of baricitinib and conventional immunomodulating therapy for alopecia totalis
- Testosterone Analysis in Hair
- INFLUENCE OF LIFESTYLE ON THE PROGNOSIS OF POLYCYSTIC OVARY SYNDROME
- Epicardial fat thickness in children with classic congenital adrenal hyperplasia
- Prace poglądowe Folate supplementation in patients with psoriasis treated with methotrexate – effect on safety and efficacy
- Metabolic syndrome and alopecia: A case-control study
- Comorbidities in Androgenetic Alopecia: A Comprehensive Review
- Non-classic congenital adrenal hyperplasia due to 21-hydroxylase deficiency revisited: an update with a special focus on adolescent and adult women
- Research gaps in medical treatment of transgender/nonbinary people
- Safety of testosterone use in women
- Surrogate end-points or primary outcomes in clinical trials in women with polycystic ovary syndrome?
- Gonadal Suppressive and Cross‐Sex Hormone Therapy for Gender Dysphoria in Adolescents and Adults
- Cardiovascular Toxicities of Androgen Deprivation Therapy
- Cardiovascular Disease-Associated Skin Conditions
- Association of Primary Cicatricial Alopecia with Subsequent Cardiovascular Disease
- No Increased Cardiovascular Hazard with Oral 5-Alpha-Reductase Inhibitors in Treatment of Androgenetic Alopecia: A TriNetX Retrospective Cohort Study
- Association between androgenetic alopecia and cardiovascular diseases: a genetic correlation and Mendelian randomization study
- Metabolic Syndrome, Cardiovascular Disease and the Hair Growth Cycle: Addressing hair growth disruptions using Nourkrin® with Marilex® as a proteoglycan replacement therapy: A concise review